CIK 0001782223 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831160910
- Phone
- (617) 221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- EFFECT Other Notice of Effectiveness
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Acquisition or sale completed · Executive or director change · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
Page 10 of 18 · 357 filings